gimli
INDGN stock analysis context
INDEGENE Stock Context for AI Screening
INDEGENE LIMITED is a small-cap stock in Healthcare. This page summarizes key screening signals for INDEGENE, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about INDGNPrice
₹508.55
1M return
+1.98%
3M return
+4.84%
Market cap
₹12,221.33 cr
PE
27.37
ROE
+22.08%
RSI
50.49
Turnover
₹3.68 cr
Why it can matter in screens
- Momentum: INDGN is above 50DMA; RSI is 50.49.
- Returns: 1M +1.98%, 3M +4.84%, 6M -0.29%.
- Liquidity: latest turnover is ₹3.68 cr.
- Valuation: PE 27.37, PB n/a, ROE +22.08%, ROCE +25.76%.
- Growth: 3Y sales CAGR +19.48%, 3Y profit CAGR +35.14%.
Try these prompts
- Analyze INDEGENE with valuation, momentum and industry peers
- Compare INDGN with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare INDGN with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.